BRIEF-Immune Pharma announces initiation of enrollment in clinical trial with Ceplene
June 20, 2017 at 09:20 AM EDT
* Immune pharmaceuticals announces initiation of enrollment in clinical trial with ceplene®/ low-dose il-2 in chronic myelomonocytic leukemia (cmml)